Search
for
Sort by
Research 61–90 of 94
- UK High Court Revokes Escitalopram UK Patent; Validity of Second Medical use Claims Based on Dosage Regimes in the UK; Stay of Proceedings in the UK Courts Pending EPO Opposition Proceedings
- Gender Differences in Skin Aging and the Changing Profile of the Sex Hormones with Age
- Abnormal essential fatty acid composition of tissue lipids in genetically diabetic mice is partially corrected by dietary linoleic and γ-linolenic acids
- Erythropoietin promotes hair shaft growth in cultured human hair follicles and modulates hair growth in mice
- Androgens and erythropoiesis. Induction of erythropoietin-hypersecretory state and effect of finasteride on erythropoietin secretion
- Cytokines
- Alopecia in three women of southeast asian descent with chronic renal failure: Possible association with erythropoietin use
- Nanoparticle-enhanced plant extracts and erythropoietin analogues for treating third-degree burns in rats: A systematic review of regenerative therapeutic strategies
- 2063-LB: Transgenic Erythropoietin Overexpression Inhibits Dermal Fat Formation and HIF1a in the Skin and Causes Telogen Effluvium in Mouse Pups during the First Hair Cycle
- Effect of Evening Primrose Oil on Hyperandrogenism Markers in Women With Polycystic Ovarian Syndrome
- Generic competition and pharma patent strategies - a sequel
- New frontiers in human hair follicle (neuro‐)endocrinology
- Improvement in physicochemical parameters of DPPC liposomes and increase in skin permeation of aciclovir and minoxidil by the addition of cationic polymers
- New potential chemotherapy for ovarian cancer — Combined therapy with WP 631 and epothilone B
- 'The Byzantine logic of patent law jurisprudence': patent protection for dosage regimes revisited
- Recent European legal developments on second medical uses and dosage regimes
- Spironolactone for treatment of female pattern hair loss
- Mental, Behavioral And Physical Effects Of Power Enhancing Drugs In Chronic Users
- BJD Editor's Choice
- Cutaneous reactions to recombinant cytokine therapy
- Alopecia Areata Treatment Patterns, Healthcare Resource Utilization, and Comorbidities in the US Population Using Insurance Claims
- Pegylated-interferon-α<sub>2a</sub>in clinical practice: how to manage patients suffering from side effects
- Feasibility of implementing current best clinical practice for people who are using anabolic androgenic steroids within a Swiss primary care practice: a quality assurance study
- Structural studies of two solid steroid compounds
- Novel drugs of United States Food and Drug Administration approved in 2024
- A Case Report of Autoimmune Hemolytic Anemia with Deep Vein Thrombosis in a 16-year-old Girl - Is It Systemic Lupus Erythematosus?
- Alopecias
- Abstracts of Communications
- Use of Complementary Alternative Medicine and Supplementation for Skin Disease
- Immune-mediated Coombs negative intravascular haemolysis in systemic lupus erythematosus (SLE)